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Abstract
Background: Bacteraemia is still a major cause of case fatality in all age groups. Our aim was to
identify the major underlying conditions constituting risk factors for case fatality in bacteraemia
patients.
Methods: The study involved 149 patients (79 male and 70 female) with bacteraemia caused by
Staphylococcus aureus (S. aureus) (41 patients), Streptococcus pneumoniae (Str. pneumoniae) (42
patients),  β-hemolytic streptococcae (β-hml str.) (23 patients) and Eschericia coli (E. coli) (43
patients). Underlying diseases, alcohol and tobacco consumption and body mass index (BMI) were
registered. Laboratory findings and clinical data were registered on admission and 6 consecutive
days and on day 10–14. Case fatality was studied within 30 days after positive blood culture.
Associations between underlying conditions and case fatality were studied in univariate analysis and
in a multivariate model.
Results: Nineteen patients (12.8%) died of bacteraemia. We found obesity (p = 0.002, RR 9.8; 95%
CI 2.3 to 41.3), smoking (p < 0.001, RR 16.9; 95% CI 2.1 to 133.5), alcohol abuse (p = 0.008, RR
3.9; 95% CI 1.3 to 11.28), COPD (p = 0.01, RR 8.4; 95% CI 1.9 to 37.1) and rheumatoid arthritis
(p = 0.045, RR 5.9; 95% CI 1.2 to 28.8) to be significantly associated with case fatality in bacteraemia
in univariate model. The median BMI was significantly higher among those who died compared to
survivors (33 vs. 26, p = 0.003). Obesity and smoking also remained independent risk factors for
case fatality when their effect was studied together in a multivariate model adjusted with the effect
of alcohol abuse, age (continuos variable), sex and causative organism.
Conclusion: Our results indicate that obesity and smoking are prominent risk factors for case
fatality in bacteraemic patients. Identification of risk factors underlying fatal outcome in bacteraemia
may allow targeting of preventive efforts to individuals likely to derive greatest potential benefit.
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Background
Bacteraemia is a common infection with significant mor-
bidity and in most severe instances also mortality. The
importance of underlying conditions such as immunosu-
pression, ultimately and rapidly fatal diseases and chronic
organ insufficiency for bacteraemia outcome has been
emphasized in a number of studies [1-3].
Obesity is an increasing health concern in Western coun-
tries. In the general population, a relationship between
obesity and increased mortality has been shown [4-6].
Data on the incidence and outcome of specific infections,
especially community-acquired infections, in obese peo-
ple are so far limited [7]. There are no papers on the effect
of obesity on case fatality in bacteraemia patients.
Smokers and alcohol abusers display an increased suscep-
tibility to bacterial infections, especially those involving
the lung. In addition, smoking [8] and alcoholism [9] are
major risk factors for invasive pneumococcal disease.
There are data showing that alcoholism is a risk factor for
case fatality in S. aureus [10] and Str. pneumoniae bacterae-
mia [11,12]. However, some studies have found no statis-
tically significant association between alcoholism and
case fatality [2,3,13]. A recent study of epidemiological
and clinical features as potential prognostic factors for
outcomes of hospital-acquired bacteraemia found no dif-
ferences between non-survivors and survivors in sex, age
or smoking habit [14]. In bacteraemias other than pneu-
mococcal, the effect of smoking and alcoholism on case
fatality has not been widely studied.
Moreover, studies of bacteraemia with varying disease
severity are few in number. Most materials in this field
consist of patients merely treated with severe infection in
ICU; patients originally evincing milder signs and symp-
toms of infection are not included. The aim of our study
was to elucidate the underlying conditions, especially the
role of obesity, smoking and alcohol abuse, as risk factor
for case fatality in bacteramia.
Methods
The study material comprised 149 patients (79 male and
70 female) with bacteraemia hospitalized in Tampere
University Hospital, Tampere, Finland, from June 1999 to
February 2004. Their ages ranged from 16 to 93 years
(mean 59 years).
In our hospital blood cultures are routinely taken from
patients with symptoms or signs of systemic infection
(fever or hypothermia, tachycardia or tachypnea com-
bined with leucocytosis or leucopenia and/or elevated C-
reactive protein (CRP)). The study focused on patients
with bactaeremia caused by S. aureus, Str. pneumoniae, β-
hml str. or E. coli, the most common causative organisms
among community-acquired bacteraemia. Patients were
identified according to microbiological culture finding.
The clinicians (J.S. or J.La.) were informed by clinical
microbiologist (R.V.) of a positive blood culture from
Mondays to Thursdays and the patients were enrolled to
the study whenever possible to adjust to the daily sched-
ule. We were able to recruit zero to two patients per week
during the study period. Since the clinicians were unable
to know any details about the patients nor their disease
severity before the recruitment, the selection was purely
based on the blood culture finding. After being informed
by clinical microbiologist the clinician asked patients to
participate and interviewed and examined those consent-
ing. Information was gathered from hospital records at
the time of hospital visit and hospital records were also
reviewed after hospitalization (R.H.). Altogether 149 out
of 152 patients agreed to participate. The causative organ-
isms involved were S. aureus (41 patients, 27.5 %), Str.
pneumoniae (42 patients, 28.2%), β-hml str. (23 patients,
15.4%), and E. coli (43 patients, 28.9%). Patients with
two episodes of bacteraemia were not included in the
study. During the period in question the BACTEC 9240
(BD Diagnostic Systems, Sparks, MD, USA) blood culture
system with standard media was used. Bacteraemia was
defined hospital-aqcuired (nosocomial) if positive blood
culture was drawn >48 h after admission.
Underlying conditions, social status and alcohol and
tobacco consumption were registered. Alcohol abuse was
defined as consumption of 300 g absolute alcohol per
week or a known social or medical problem due to alco-
hol use. Smoking habits were registered and patients were
defined as current smokers, ex-smokers i.e. those who
have stopped smoking and nonsmokers i.e. those who
have never smoked (data available from 136 out of 149
patients). Calculation of BMI was based on weight and
length as reported by the patient on admission. BMI was
recorded and patients were defined as obese if their BMI
was > 30 (data available from 114 out of 149 patients; 10/
19 of deceased patients and 104/128 of survivors).
Chronic diseases were registered and McCabe (and Jack-
son) classification was used to assess the severity of the
underlying medical condition [15]. Preceding corticoster-
oid treatment was registered if corticosteroids were used
in a dose of over 5 mg per day during 1 month before the
bacteremia episode. All patients were treated with an
empiric antibiotic regimen and antimicrobial treatment
was changed according to culture results if necessary.
Patients were closely monitored during hospitalization
and severely ill subjects were transferred to the ICU. Clin-
ical data were registered on admission and during 6 con-
secutive days and on day 10–14 after admission. Possible
need for mechanical ventilation was registered. Altera-
tions in mental status were evaluated on the GlasgowBMC Infectious Diseases 2007, 7:13 http://www.biomedcentral.com/1471-2334/7/13
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Coma Scale (GCS). A patient was classified hypotensive if
mean arterial pressure (MAP) was < 70 mmHg during the
bacteraemia episode.
A SOFA score (Sequential Organ Failure Assessment) [16]
was calculated on 1–3 days after positive blood culture
finding (data available from 135/149 patients). Severe
organ failure was documented if the SOFA score was ≥ 4.
A patient did not need ICU treatment if the SOFA score
was lower than 4. Laboratory findings were registered on
admission, during 6 consecutive days and on day 10–14.
The laboratory tests included plasma C-reactive protein
(mg/l), blood white cell count (× 109/l), blood platelets
(× 109/l), plasma bilirubin (µmol/l), plasma creatinine
level (µmol/l), plasma alanine aminotransferase (U/l)
and plasma alkaline phosphatase (U/l). The case fatality
rate was studied within 30 days after the positive blood
culture (day 30 case fatality).
The study was approved by the Ethics Committee of Tam-
pere University Hospital. Written informed consent was
obtained from patients or first degree relatives.
The SPSS package (version 7.5) was used for statistical
analyses and a two-sided p-value < 0.05 was taken as the
level for statistical significance. Categorical data were ana-
lysed by X2 test or Fisher's exact test when appropriate.
Nonparametric data were analysed by Mann-Whitney U-
test. Multivariate logistic regression analysis (method
enter) was used to assess the effects of independent factors
on mortality, controlling for differences in other factors
possibly affecting the outcome. Risk ratios (RRs) were
expressed with their 95% confidence intervals (CI). We
studied the effect of obesity, smoking and alcohol abuse
in a multivariate model adjusted with the effect of age
(continuous variable), sex and organism (S. Aureus, Str.
Pneumoniae, β-hl str., or E. coli).
Results
Nineteen patients (12.8%) died of bacteraemia. The case
fatality rate differed in bacteraemias caused by different
organisms: S. aureus 8/41 (19.5%), Str. pneumoniae 8/42
(19.0%), β-hml str.2/23 (8.7%), and E. coli 1/43 (2.3%).
Bacteraemia was community-acquired in 119 patients
(79.9%) and nosocomial in 30 (20.1%).
Predisposing factors and underlying diseases of bacterae-
mia are given in Table 1. Four differed bacteraemias dif-
fered statistically significantly from each other in the
number of smoking patients (current smokers or ex-
smokers, p = 0.007). Smoking was common in pneumo-
coccal bacteraemic patients (65.0% of patients current
smokers or ex-smokers) whereas 27.5% of E. coli bacterae-
mic patients were current smokers or ex-smokers. S. aureus
bacteraemia was the most common pathogen in patients
with rheumatoid arthritis. Bacteramias differed statisti-
cally significantly from each other in the number of male
patients (p = 0.003). Only 30.2% of E. coli bacteramia
patients were male whereas 68.3% of S. aureus bacterae-
mic patients were male. S. aureus was a common pathogen
in nosocomial infection; 39% of S. aureus bacteraemias
were nosocomial infections.
The sources of the infection were identifiable in 132
patients and are listed in Table 2. Clinical data on all
patients and on patients with bacteraemia caused by dif-
ferent organisms are shown in Table 3. The case fatality
rate in relation to predisposing factors and underlying dis-
eases is given in Table 4. Obesity, smoking, alcohol abuse,
COPD and rheumatoid arthritis proved significant risk
factors for case fatality in univariate analysis (table 4).
Myocardial infarction occurred in 11 (7.4%) patients and
cerebral infarction in 7 (4.7%) during the month follow-
ing positive blood culture. Twenty-six per cent of patients
older than 60 years were treated in ICU compared to 38
per cent of those aged 60 or younger (p = 0.104).
Obesity
Day 30 case fatality was higher in obese bacteraemic
patients than in nonobese patients (25.9% vs. 3.4%, p =
0.002, RR 9.8; 95% CI 2.3–41.3). The median BMI was
significantly higher among those who died compared to
survivors (33 vs. 26, p = 0.003). Obese and nonobese
study groups did not differ statistically significantly from
each other in numbers needing ICU treatment (25.9% vs.
28.7%, p = 0.78, RR 0.9; 95% CI 0.3–2.3). Obese patients
needed mechanical ventilation more often than non-
obese, but the difference was not statistically significant
(18.5% vs 8.0%, p = 0.152, RR 2.6; 95% CI 0.8–9.0).
However, more obese than nonobese patients died in ICU
treatment (5/7 vs. 3/25; p = 0.005, RR 18.3; 95% CI 2.4–
140.4). The obese had high SOFA scores (value >4 on day
1–3 after positive blood culture finding) more often than
nonobese, but the difference was not statistically signifi-
cant (44.0% vs 23.8%, p = 0.05, RR 2.5; 95% CI 1.0–6.5).
The obese and nonobese groups did not differ statistically
significantly in the occurrence of hypotension (37.0% vs
31.0%, p = 0.561, RR 1.3; 95% CI 0.5–3.2), or in the
number of patients with neurological deficit (lowered
GCS) (44.4% vs 33.3%, p = 0.293, RR 1.6; 95% CI 0.7–
3.9)
Forty-four per cent of obese bacteraemic patients had pre-
viously been diagnosed with type 2 diabetes as against
12.6% of nonobese patients (p < 0.001). Patients with
type 2 diabetes died more often than those without type 2
diabetes, but the difference was not statistically significant
(Table 4).BMC Infectious Diseases 2007, 7:13 http://www.biomedcentral.com/1471-2334/7/13
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Table 2: Source of bacteraemiaa
Focus All S. aureus Str. pneumoniae β-hml str. E. coli
n = 170b n = 56b n = 45b n = 29b n = 40b
(%) (%) (%) (%) (%)
Pneumonia 39 (22.9) 2 (3.6) 35 (77.8) 2 (6.9) 0 (0)
Skin 37 (21.8) 19 (33.9) 2 (4.4) 16 (55.2) 0 (0)
Urinary 30 (17.6) 1 (1.8) 0 (0) 1 (3.4) 28 (70.0)
Source unknown 17 (10.0) 3 (5.4) 4 (8.9) 3 (10.3) 7 (17.5)
Osteomyelitis/spondylitis 15 (8.8) 12 (21.4) 0 (0) 3 (10.3) 0 (0)
Gall bladder 7 (4.1) 0 (0) 3 (6.7) 0 (0) 4 (10.0)
Endocarditis 6 (3.5) 6 (10.7) 0 (0) 0 (0) 0 (0)
Arthritis 6 (3.5) 5 (8.9) 0 (0) 1 (3.4) 0 (0)
Mediastinitis 4 (2.4) 4 (7.1) 0 (0) 0 (0) 0 (0)
Meningitis 3 (1.8) 1 (1.8) 1 (2.2) 1 (3.4) 0 (0)
Gynaecological 3 (1.8) 0 (0) 0 (0) 2 (6.9) 1 (2.5)
Intravenous/intra-arterial catheter-related 3 (1.8) 3 (5.4) 0 (0) 0 (0) 0 (0)
aOne patient may have several focuses
bIndicating the number of focuses
Table 1: Predisposing factors and underlying diseases of bacteraemia
Predisposing factor All patients S. aureus Str. pneumoniae β-haemolytic streptococci E. coli p-value
N = 149 N = 41 N = 42 N = 23 N = 43
n (%) n (%) n (%) n (%) n (%)
Obesitya 27 (23.7) 9 (25.7) 4 (16.7) 6 (31.6) 8 (22.2) 0.698
Current smoker or ex-smokerb 66 (48.5) 18 (48.6) 26 (65.0) 11 (57.9) 11 (27.5) 0.007
Alcohol abuse 24 (16.1) 5 (12.2) 9 (21.4) 6 (26.1) 4 (9.3) 0.211
Type 1 diabetes 5 (3.4) 1 (2.4) - - 4 (9.3) 0.1
Type 2 diabetes 29 (19.5) 9 (22.0) 5 (11.9) 4 (17.4) 11 (25.6) 0.426
COPD 8 (5.4) - 5 (11.9) 2 (8.7) 1 (2.3) 0.053
Haematological malignancy 11 (7.4) 2 (4.9) 3 (7.1) 1 (4.3) 5 (11.6) 0.723
Solid malignancy 15 (10.1) 6 (14.6) 3 (7.1) 1 (4.3) 5 (11.6) 0.589
Rheumatoid arthritis 7 (4.7) 5 (12.2) - 1 (4.3) 1 (2.3) 0.034
Liver cirrhosis 4 (2.7) 2 (4.9) - 1 (4.3) 1 (2.3) 0.511
Cardiac diseasec 44 (29.5) 14 (34.1) 10 (23.8) 6 (26.1) 14 (32.6) 0.705
McCabe II or IIId 24 (16.1) 8 (19.5) 5 (11.9) 2 (8.7) 9 (20.9) 0.462
Corticosteroid treatmente 18 (12.1) 6 (14.6) 4 (9.5) 2 (8.7) 6 (14.0) 0.857
Chronic diseasef 117 (78.5) 33 (80.5) 27 (64.3) 17 (73.9) 40 (93.0) 0.013
Age >60 years 78 (52.3) 21 (51.2) 20 (47.6) 10 (43.5) 27 (62.8) 0.391
Male sex 79 (53.0) 28 (68.3) 24 (57.1) 14 (60.9) 13 (30.2) 0.003
Nosocomial infection 30 (20.1) 16 (39.0) 4 (9.5) 3 (13.0) 7 (16.3) 0.004
a(BMI >30), data available from 114 patients
bData available from 136 patients
cCoronary artery disease, valvular disease or documented heart failure
dMcCabe class II or III: ultimately fatal or rapidly fatal disease
eCorticosteroids used in a dose of over 5 mg per day during one month prior to the episode of bacteraemia
fAt least one chronic diseaseBMC Infectious Diseases 2007, 7:13 http://www.biomedcentral.com/1471-2334/7/13
Page 5 of 8
(page number not for citation purposes)
Table 4: Case fatality in relation to predisposing factors and underlying diseases (univariate analysis)
Predisposing factor All patients Deceased Survivors p-value RR (95% CI)
N = 149 N = 19 N = 130
n (%) n (%) n (%)
Obesitya 27 (23.7) 7 (70.0) 20 (19.2) 0.002 9.8 (2.3–41.3)
Current smoker or ex-smokerb 66 (48.5) 13 (92.9) 53 (43.4) <0.001 16.9 (2.1–133.5)
Alcohol abuse 24 (16.1) 7 (36.8) 17 (13.1) 0.008 3.9 (1.3–11.2)
Type 1 diabetes 5 (3.4) 0 (0) 5 (3.8) 1 1.0 (0.9–1.0)
Type 2 diabetes 29 (19.5) 6 (31.6) 23 (17.7) 0.153 2.1 (0.7–6.2)
COPD 8 (5.4) 4 (21.1) 4 (3.1) 0.01 8.4 (1.9–37.1)
Haematological malignancy 11 (7.4) 0 (0) 11 (8.5) 0.36 0.9 (0.9–1.0)
Solid malignancy 15 (10.1) 3 (15.8) 12 (9.2) 0.41 1.8 (0.5–7.2)
Rheumatoid arthritis 7 (4.7) 3 (15.8) 4 (3.1) 0.045 5.9 (1.2–28.8)
Liver cirrhosis 4 (2.7) 1 (5.3) 3 (2.3) 0.42 2.4 (0.2–23.8)
Cardiac diseasec 44 (29.5) 6 (31.6) 38 (29.2) 0.834 1.1 (0.4–3.2)
McCabe II or IIId 24 (16.1) 3 (15.8) 21 (16.2) 1 1.0 (0.3–3.6)
Corticosteroid treatmente 18 (12.1) 2 (10.5) 16 (12.3) 0.824 0.8 (0.2–4.0)
Chronic diseasef 117 (78.5) 18 (94.7) 99 (76.2) 0.065 5.6 (0.7–43.9)
Age over 60 years 78 (52.3) 11 (57.9) 67 (51.5) 0.604 1.3 (0.5–3.4)
Male sex 79 (53.0) 14 (73.7) 65 (50.0) 0.053 2.8 (1.0–8.2)
Nosocomial infection 30 (20.1) 1 (5.3) 29 (22.3) 0.084 0.2 (0.03–1.5)
a(BMI >30), data available from 114 patients
bData available from 136 patients
cCoronary artery disease, valvular disease or documented heart failure
dMcCabe class II or III: ultimately fatal or rapidly fatal disease
eCorticosteroids used in a dose of over 5 mg per day during one month prior to the episode of bacteraemia
fAt least one chronic disease
Table 3: Clinical data on 149 patients with 4 different bacteraemias
Disease severity All S. aureus Str. Pneumoniae β-hemolytic streptococci E. coli p-value*
n = 149 n = 41 n = 42 n = 23 n = 43
(%) (%) (%) (%) (%)
Dieda 19 (12.8) 8 (19.5) 8 (19.0) 2 (8.7) 1 (2.3) 0.031
Needed ICU stay 47 (31.5) 15 (36.6) 16 (38.1) 10 (43.5) 6 (14.0) 0.029
Needed mechanical ventilation 22 (14.8) 7 (17.1) 10 (23.8) 3 (13.0) 2 (4.7) 0.092
Needed CVVHD 7 (4.7) 5 (12.2) 0 (0) 2 (8.7) 0 (0) 0.006
Needed haemodialysis 2 (1.3) 2 (4.9) 0 (0) 0 (0) 0 (0) 0.097
Sofa Score >4b 39 (28.9) 9 (25.0) 10 (26.3) 11 (50.0) 9 (23.1) 0.122
Low platelet countc 21 (14.1) 8 (19.5) 3 (7.1) 4 (17.4) 6 (14.0) 0.411
Elevated bilirubin leveld 51 (34.2) 14 (34.1) 12 (28.6) 10 (43.5) 15 (34.9) 0.687
Lowered GCSe 60 (40.3) 19 (46.3) 18 (42.9) 10 (43.9) 13 (30.2) 0.45
Hypotensivef 56 (37.6) 13 (31.7) 19 (45.2) 11 (47.8) 13 (30.2) 0.299
aDeath due to bacteraemia episode occurred within 30 days from the day of positive blood culture.
bSOFA score was registered 1–4 days after positive blood culture finding (median 3 days). Data available from 135 patients.
cPlatelet count at least once lower than 50 10E9/L 0–8 days after positive blood culture
dBilirubin level elevated (>25 µmol/L) at least once 0–8 days after positive blood culture
eGlasgow coma scale lowered (<15) at least once 0–6 days after positive blood culture
fHypotensive (MAP <70 mmhg) at least once 0–6 days after positive blood culture
*The difference between groups of patients with bacteraemia caused by different organismsBMC Infectious Diseases 2007, 7:13 http://www.biomedcentral.com/1471-2334/7/13
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Smoking
The day 30 case fatality rate in bacteraemic patients was
higher in current or ex-smokers than in nonsmokers
(19.7% vs. 1.4%, p < 0.001, RR 16.9; 95% CI 2.1–133.5);
ninety-three per cent of patients who died were current or
ex-smokers (Table 4). Current or ex-smokers needed ICU
treatment (39.4% vs 18.6%, p = 0.007, RR 2.9; 95% CI
1.3–6.2) and mechanical ventilation (21.2% vs 5.7%, p =
0.008, RR 4.4; 95% CI 1.4–14.3) more often than non-
smokers during the bacteremia episode. Current or ex-
smokers died more often in ICU treatment compared to
nonsmokers (10/26 vs 1/13, p = 0.044, RR 7.5; 95% CI
0.8–66.9) and had high SOFA scores (value > 4 on day 1–
3 after positive blood culture finding) more often than
nonsmokers (33.3% vs 16.4%, p = 0.029, RR 2.6; 95% CI
1.1–6.0). The current or ex-smoker patient groups did not
differ statistically significantly from the nonsmoker group
in the occurrence of hypotension (42.4% vs 28.6%, p =
0.091, RR 1.8; 95% CI 0.9–3.8) or in numbers with neu-
rological deficit (lowered GCS) (43.9% vs 32.9%, p =
0.184, RR 1.6; 95% CI 0.8–3.2).
Thirty-eight patients (35.2%) were current smokers while
70 (64.8%) had never smoked. When current smokers
were compared to nonsmokers (ex-smokers excluded
from this analysis) the adverse effect of smoking for prog-
nosis of bacteraemia was emphasized. The day 30 case
fatality rate in bacteraemic patients were higher in current
smokers than in nonsmokers (21.1% vs. 1.4%, p < 0.001,
RR 18.4; 95% CI 2.2–153.7). Current smokers needed
ICU treatment (50.0% vs 18.6%, p = 0.001, RR 4.4; 95%
CI 1.8–10.5) and mechanical ventilation (31.6% vs 5.7%,
p < 0.001, RR 7.6; 95% CI 2.3–25.8) more often than non-
smokers during the bacteremia episode. This adverse
effect remained even after smoking cessation; 5/28
(17.9%) patients died in the ex-smoker group compared
to 1/70 (1.4%) of those who had never smoked (p =
0.007, RR 15.0; 95% CI 1.7–135.1). Fifty-nine per cent of
males were current or ex-smokers as against 36.9% of
females (p = 0.01).
Alcohol abuse
The day 30 case fatality rate in bacteraemic patients was
higher in alcohol abusers compared to those not given to
alcohol abuse (29.2% vs 9.6%, p = 0.008, RR 3.9; 95% CI
1.3–11.2). Alcohol abusers needed ICU treatment (66.7%
vs 24.8%, p < 0.001, RR 6.1; 95% CI 2.4–15.5) and
mechanical ventilation (41.7% vs 9.6%, p < 0.001, RR
6.7;95% CI 2.5–18.4) more often than those not abusing.
Alcohol abusers died more often in ICU treatment, the
difference being, however, not statistically significant (7/
16 vs 8/31, p = 0.211, RR 2.2, 95% CI 0.6–8.0). Alcohol
abusers had high SOFA scores (value >4 on day 1–3 after
positive blood culture finding) more often than those
without alcohol abuse (65.2% vs 21.4%, p < 0.001, RR
6.9; 95% CI 2.6–18.1). The occurrence of hypotension
was more common among abusers than in their counter-
parts (70.8% vs 31.2%, p < 0.001, RR 5.4; 95% CI 2.1–
14.0) and were more likely to develop neurological deficit
(lowered GSC) (75.0% vs 33.6%, p < 0.001, RR 5.9; 95%
CI 2.2–16.0). Eighteen out of 21 (85.7%) alcohol abusers
were current smokers or ex-smokers and 4 out of 24
(16.7%) had liver cirrhosis.
The effect of obesity, smoking and alcohol abuse on day
30 case fatality were studied together with age, sex and
organism in a multivariate model. Obesity remained a sig-
nificant risk factor associated with case fatality also in this
adjusted model (p = 0.03, RR 6.4; 95% CI 1.2–34.4),
together with smoking (P = 0.02, RR 23.0; 95% CI 1.7–
321.6).
Discussion
Obesity, smoking, alcohol abuse, COPD and rheumatoid
arthritis proved to be significantly associated with case
fatality in bacteraemia in univariate model. The effect of
obesity and smoking on case fatality also remained signif-
icant when studied in a multivariate model together with
alcohol abuse, age (continuos variable), sex and causative
organism.
Instead of focusing on the clinical findings associated
with poor prognosis in bacteraemia, which have been well
studied (such as hypotension, leukopenia or leukocytosis
or the number of evolving organ dysfunctions) [17,18],
we sought to focus on the underlying conditions and
chronic illnesses possibly constituting risk factors for case
fatality in bacteraemic patients. Most studies in this field
deal with patients with severe bacteraemia requiring ICU
treatment [3,18]. One of the major advantages of our
study was the enrolment of patients evincing different dis-
ease severity; patients with milder symptoms and signs as
well as patients with septic shock who needed ICU treat-
ment. One of the limitations was that we could not enrol
all patients with bacteraemia in our university hospital
district during the study period. This limitation excludes
determination of population-based incidence rates. How-
ever, the investigators did not select the patients they
included in the study, the inclusion being based on the
microbiological culture finding, and all patients having
the same possibility to be recruited by the investigators
from Mondays to Thursdays during the study period.
Since the clinicians were unable to know any details about
the patients nor their disease severity before the recruit-
ment, the selection was purely based on the blood culture
finding. This kind of recruitment of patients probably did
not cause any selection bias.
Obesity emerged as an independent risk factor for case
fatality and obese patients died more often despite ICUBMC Infectious Diseases 2007, 7:13 http://www.biomedcentral.com/1471-2334/7/13
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treatment compared to nonobese patients. The published
studies examining the association between obesity and in-
hospital case fatality give conflicting results concerning
the role of body mass index (BMI) as a risk factor for in-
hospital case fatality. We found no studies reporting
increased mortality due to bacteraemia among obese
patients. There are three papers reporting an increased
obesity-related case fatality rate in ICU [19-21], these
involving patients with multiple reasons for ICU admis-
sion, not only infectious causes. In contrast to our study
there are also studies where high BMI is not found to be a
predictor of case fatality in ICU patients [22-25], and
where a low BMI is independently associated with higher
case fatality [22,23].
The physiologic mechanisms prevailing between obesity
and mortality are unknown. It remains obscure which fac-
tors contribute to the increased case fatality in obese in-
hospital patients reported in some series. One study
showed that obesity exacerbates sepsis-induced inflam-
mation and microvascular dysfunction in the mouse brain
[26]. The investigators in question noted microvascular
inflammatory and thrombogenic responses, including
activation of endothelial cells with subsequent expression
of adhesion molecules such as P-selectin in obese mice
[26]. Bornstein and associates found that plasma leptin
levels are increased in survivors of acute sepsis [27]. The
group found that mean leptin levels were three-fold
higher in patients who survived the episode than in non-
survivors, and concluded that in addition to its function
as an anti-obesity factor, leptin may play a role in a severe
stress state such as acute sepsis [27]. Recent findings indi-
cate that obesity is an independent risk factor for lipid per-
oxidation [28] and impaired endothelial cell function
[29]. In addition, there appears to be a chronic low-grade
inflammation state with elevated acute-phase mediators,
cytokines and soluble adhesion molecules which persists
in obese individuals [30,31].
Smoking was an independent risk factor for case fatality
due to bacteraemia in our study. The effect was most dis-
tinct when current smokers were compared to nonsmok-
ers, but it also remained significant after smoking
cessation. Smokers more often needed mechanical venti-
lation and ICU stay, their SOFA score was more often
higher than in nonsmokers and they died more often
despite ICU treatment. Although the importance of smok-
ing cessation has been emphasized in the therapeutic plan
of patients with serious infections [32], there are only a
few other studies of the effect of smoking on case fatality
in bacteraemia. Arvanitidou and colleagues studied epide-
miological and clinical features as potential prognostic
factors for outcomes of hospital-acquired bacteraemia in
a tertiary care teaching hospital in Greece [14]. They found
no differences between non-survivors and survivors in sex,
age or smoking habit [14]. Pittet and associates concluded
that smoking or alcohol abuse did not reach statistical sig-
nificance as independent risk factors for case fatality in
septicaemia. However, the number of co-morbidities, also
including smoking and alcohol abuse, predicted mortality
[2].
Alcoholism emerged as a risk factor for case fatality in uni-
variate analysis, this effect being however diminished
when studied in an adjusted model together with obesity,
smoking, sex, age and organism. This might be explained
by the fact that most alcohol abusers were also smokers,
and the effect on case fatality may thus result from smok-
ing, not alcohol itself. In accordance with our findings,
there are studies showing that alcoholism is a risk factor
for case fatality in pneumococcal bacteraemia in univari-
ate analysis [11,12]. There are however also studies where
such an association is not confirmed. Lääveri and associ-
ates found no statistically significant association between
alcohol abuse and increased case fatality in bacteraemic
pneumococcal disease [13], while a group under Laup-
land et al conducted a population-based surveillance
cohort study of severe bloodstream infections and found
that alcoholism increased the case fatality rate in bacterae-
mic patients althought the difference was not statistically
significant [3].
We had seven patients with rheumatoid arthritis, three of
whom died of bacteraemia. The number of patients with
rheumatoid arthritis is small, but the results in univariate
model suggest that rheumatoid patients have increased
case fatality in bacteraemia. Sihvonen and associates con-
ducted a cross-sectional cohort study of rheumatoid
arthritis patients and concluded that they carried an
increased risk of death from various causes, and they were
at increased risk of dying of infections when compared to
the general population or controls [33].
Conclusion
In conclusion, our results indicate that obesity, together
with smoking, constitutes an important risk factor for case
fatality in bacteraemic patients. With the rising prevalence
of obesity in Western countries, future research should
focus on finding mechanisms responsible for increased
mortality in obese bacteraemic patients. The adverse effect
of smoking on bacteraemia outcome is an underestimated
health risk. Identification of risk factors underlying fatal
outcome in bacteraemia may allow targeting of preventive
efforts to individuals likely to derive greatest potential
benefit.
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